Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease

J Pineal Res. 2006 Apr;40(3):251-8. doi: 10.1111/j.1600-079X.2005.00308.x.

Abstract

In this study, the effects of melatonin on MPP+ -treated cerebellar granule neurons (CGNs) in culture were investigated. Results showed that MPP+ treatment significantly decreased cell viability and increased the apoptotic cell population at 24 and 48 hr. Calpain and caspase-3 activation was also determined, with results showing a strong increase in calpain (74%) and caspase 3 activity (70%), as measured by alpha-spectrin cleavage and fluorometric and colorimetric analysis, respectively. There are several studies suggesting that the activation of the cdk5/p35 pathway at its cleavage to cdk5/p25 may play a role in neuronal cell death in neurodegenerative diseases. Moreover, these studies indicate that this cleavage is mediated by calpains, and that MPP+ prompted an increase in cdk5 expression, as well as the cleavage of p35-p25, in a time-dependent manner. 1 mm Melatonin not only reduced the neurotoxic effects of MPP+ on cell viability, but also prevented apoptosis mediated by this Parkinsonian toxin in CGNs. 1 mm Melatonin reduced cdk5 expression, as well as the cleavage of p35-p25. These data indicate that melatonin possesses some neuro-protective properties against MPP+ -induced apoptosis. Moreover, these data suggest that the calpain/cdk5 signaling cascade has a potential role in the MPP+ -mediated apoptotic process in CGNs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Calpain / metabolism
  • Caspase 3
  • Caspases / metabolism
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cerebellum / cytology
  • Cyclin-Dependent Kinase 5 / metabolism
  • Enzyme Activation
  • Melatonin / pharmacology*
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Neurons / drug effects
  • Parkinson Disease, Secondary / chemically induced
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Nerve Tissue Proteins
  • neuronal Cdk5 activator (p25-p35)
  • Cyclin-Dependent Kinase 5
  • Calpain
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • Melatonin
  • 1-Methyl-4-phenylpyridinium